Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM2: SARS-CoV-2 Antibody Response and the Role of Serology in COVID-19 Diagnosis and Epidemiology

In this presentation, Professor Sharon Lewin discusses the kinetics of the antibody response following SARS-CoV-2 infection, current tests for antibody detection, and the use of serology assays in COVID-19 diagnosis and epidemiological studies
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: May 28, 2020

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Expert faculty discuss guideline recommendations for nontuberculous mycobacterial lung disease (NTM-LD), from Clinical Care Options (CCO)

Keira A. Cohen, MD
Program Director
person default David E. Griffith, MD Princy N. Kumar, MD, FIDSA, MACP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 19, 2021 Expired: November 18, 2022

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021

Expert selected highlights of guideline updates for nontuberculous mycobacterial lung disease (NTM-LD), from Clinical Care Options (CCO)

Keira A. Cohen, MD
Program Director
person default David E. Griffith, MD Princy N. Kumar, MD, FIDSA, MACP
Released: November 8, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue